Indrayani Biotech Ltd

₹ 55.4 -1.88%

25 Apr 10:50 a.m.

About

Incorporated in 1992, Indrayani Biotech
Ltd is in the business of Foods & Hospitality, Engineering and Healthcare^[1]

Key Points

Business Overview:^[1]
IBL has multiple business units managed by an
independent team of field experts. It operates
in Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure

Website BSE

Market Cap ₹ 189 Cr.
Current Price ₹ 55.4
High / Low ₹ 99.7 / 46.8
Stock P/E 26.1
Book Value ₹ 16.8
Dividend Yield 0.00 %
ROCE 23.0 %
ROE 36.2 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is expected to give good quarter

Cons

Stock is trading at 3.35 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
Promoter holding is low: 33.6%
Tax rate seems low
Company has a low return on equity of 12.0% over last 3 years.
Promoter holding has decreased over last 3 years: -16.8%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Hotels & Restaurants Industry: Hotels

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	5.81	7.16	14.31	14.85	15.25	17.25	25.63	42.05	46.00	49.25	42.31	40.44	39.09
	4.89	7.74	13.28	13.21	13.40	15.02	22.60	36.85	40.67	46.07	39.77	33.15	35.64
Operating Profit	0.92	-0.58	1.03	1.64	1.85	2.23	3.03	5.20	5.33	3.18	2.54	7.29	3.45
OPM %	15.83%	-8.10%	7.20%	11.04%	12.13%	12.93%	11.82%	12.37%	11.59%	6.46%	6.00%	18.03%	8.83%
	-2.09	-1.86	0.04	0.04	0.15	0.01	0.39	1.96	0.08	2.05	0.01	0.09	0.08
Interest	0.35	1.00	0.32	0.53	0.59	0.44	0.97	1.15	1.21	2.23	2.03	0.93	1.41
Depreciation	0.22	-0.19	0.11	0.11	0.27	0.18	0.66	0.75	0.78	1.15	0.90	0.91	1.03
Profit before tax	-1.74	-3.25	0.64	1.04	1.14	1.62	1.79	5.26	3.42	1.85	-0.38	5.54	1.09
Tax %	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	0.62%	-0.00%	-0.00%	-0.88%	21.62%	-15.79%	-0.00%	-0.00%
	-1.74	-3.25	0.65	1.04	1.15	1.61	1.79	5.26	3.44	1.44	-0.45	5.54	1.08
EPS in Rs	-0.51	-0.95	0.19	0.30	0.34	0.44	0.52	1.54	0.72	0.32	-0.13	1.62	0.32
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2010	Mar 2011	Mar 2012	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
	0	39	58	50	21	61	163	171
	0	39	57	47	26	54	145	155
Operating Profit	-0	1	1	3	-5	7	17	16
OPM %	-105%	2%	1%	6%	-24%	11%	11%	10%
	0	-0	0	0	-4	0	4	2
Interest	0	0	0	1	2	2	6	7
Depreciation	0	0	0	1	0	1	3	4
Profit before tax	-0	0	0	1	-11	4	12	8
Tax %	-0%	150%	300%	-0%	-0%	-0%	3%
	-0	-0	-0	1	-11	4	12	8
EPS in Rs		-0.14	-0.16	2.22	-3.28	1.30	3.49	2.13
Dividend Payout %	-0%	-0%	-0%	-0%	-0%	-0%	-0%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	48%
TTM:	31%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	148%
TTM:	-34%

Stock Price CAGR
10 Years:	%
5 Years:	59%
3 Years:	109%
1 Year:	-26%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	12%
Last Year:	36%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2010	Mar 2011	Mar 2012	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2023
Equity Capital	6	4	4	4	34	34	34	43
Reserves	-6	-0	-0	27	-15	-10	10	14
Preference Capital	-0	-0	-0	-0	-0	-0	9
	0	-0	-0	14	16	19	70	88
	1	6	9	7	5	8	41	33
Total Liabilities	1	10	12	51	40	51	156	179
	1	6	6	17	15	17	57	57
CWIP	-0	-0	-0	14	14	13	14	14
Investments	-0	-0	-0	0	0	-0	0	9
	0	4	7	21	11	22	85	100
Total Assets	1	10	12	51	40	51	156	179

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2011	Mar 2012	Mar 2020	Mar 2021	Mar 2022	Mar 2023
	1	2	6	0	4	16
	-3	-0	-4	-1	-1	-47
	2	-1	-1	-0	-3	33
Net Cash Flow	0	1	1	-1	1	2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2010	Mar 2011	Mar 2012	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	-0	26	26	52	84	84	67
Inventory Days	365			57	25	14	44
Days Payable	365			70	77	52	81
Cash Conversion Cycle	-0	26	26	38	32	46	30
Working Capital Days	-1,883	-1	-8	80	71	56	83
ROCE %		28%	12%		-13%	16%	23%

Shareholding Pattern

Numbers in percentages

	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Apr 2024
	50.39%	50.17%	48.81%	44.91%	44.89%	44.89%	44.89%	44.89%	44.84%	33.63%	33.57%	33.57%
	22.04%	22.04%	22.04%	22.04%	19.17%	17.16%	17.02%	15.27%	13.11%	7.58%	6.75%	6.75%
	27.57%	27.79%	29.15%	33.05%	35.94%	37.96%	38.09%	39.84%	42.05%	58.78%	59.68%	59.68%
No. of Shareholders	20,201	20,817	20,925	20,914	22,049	22,112	21,919	22,435	22,590	23,034	23,958	23,958

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Apr 2024
	59.39%	59.39%	72.22%	72.28%	50.39%	48.81%	44.89%	33.57%	33.57%
	0.00%	0.00%	0.00%	0.00%	22.04%	22.04%	17.02%	6.75%	6.75%
	40.61%	40.61%	27.78%	27.72%	27.57%	29.15%	38.09%	59.68%	59.68%
No. of Shareholders	18,923	18,754	18,697	18,634	18,926	20,925	21,919	23,958	23,958

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Indrayani Biotech Ltd

Indrayani Biotech Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports